Briefs: Aurobindo Pharma and Balaxi Pharmaceuticals

Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company

Zydus announces IND clearance of a novel Anti-PCSK9 candidate

Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity

SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance

SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology

Menarini strengthens its presence in aesthetic dermatology in India

The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation

Berhyanda gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals

The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company

Briefs: Sun Pharmaceutical Industries and Dr. Reddy’s

Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.

USFDA delegation visits Divi's Laboratories’ Unit I at Choutuppal, Telangana

The delegation's visit covered a wide range of topics

Doceree raises US$ 35 million in Series B Funding

Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe

USFDA inspection at Piramal Pharma’s Bethlehem facility

Hermes Pharma to invest €25 million to bolster manufacturing capabilities

The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing